← Eichor
Study identifier: NCT07026591 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Epilepsy and Driving

Condition: Epilepsy  ·  Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

PhaseN/A
Planned participants40
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

Epilepsy can lead to cognitive impairments, particularly in attention, which may affect daily activities such as driving. Driving plays a key role in maintaining autonomy and is essential for the social and professional integration of people with epilepsy. Therefore, assessing fitness to drive is a major issue for individuals with epilepsy. French legislation governing driving for people with epilepsy clearly outlines the periods during which a person is not permitted to drive. However, the means or methods for evaluating driving fitness in these individuals are not well defined. Currently, assessment is based more on a medical consultation than on a comprehensive evaluation of driving ability. Using a driving simulator in combination with an EEG could be a valuable approach to better assess the impact of epilepsy-related cognitive impairments on driving performance.

This description comes directly from the study's public registry record.

Talk to the study team

Amelie Yavchitz  ·  +33 1 48 03 64 54  ·  ayavchitz@for.paris

Always discuss trial participation with your own doctor first.

Locations (1)

Institut La TeppeTain-l'Hermitage, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07026591